Filing Details
- Accession Number:
- 0001567619-20-016184
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-08-31 19:15:48
- Reporting Period:
- 2020-08-27
- Accepted Time:
- 2020-08-31 19:15:48
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1444380 | Nevro Corp | NVRO | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1174533 | F Michael Demane | C/O Nevro Corp. 1800 Bridge Parkway Redwood City CA 94065 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2020-08-27 | 8,081 | $140.55 | 289,687 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-08-27 | 10,819 | $141.34 | 278,868 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 38,054 | Indirect | See footnote |
| Common Stock | 21,800 | Indirect | See footnote |
| Common Stock | 30,218 | Indirect | See footnote |
| Common Stock | 47,982 | Indirect | See footnote |
Footnotes
- The sale was effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
- The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $140.00 to $140.99, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- Includes 1,376 restricted stock units.
- The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $141.01 to $141.98, inclusive. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- Shares held by Catherine Q. DeMane Trustee, Michael F. DeMane 2012 Irrevocable Trust U/A/D July 26, 2012.
- Shares held by Michael DeMane Trustee, Michael F. DeMane 2016 Retailed Annuity Trust U/A/D May 22, 2017 (the "2016 Trust").
- Shares held by Michael F. DeMane, Trustee, Michael F. DeMane 2018 Retained Annuity Trust 07/16/2018 (the "2018 Trust"). 50,000 shares previously held by Michael DeMane directly were transferred to the 2018 Trust on August 7, 2018.
- Shares held by Michael F. DeMane & Catherine Q. DeMane, Trustees Michael F. DeMane Revocable Trust 10/07/2011 (the "Revocable Trust"). 11,000 shares, 10,150 shares and 7,050 shares previously held by the 2016 Trust were transferred to the Revocable Trust on August 7, 2018, August 22, 2019 and August 7, 2020, respectively. 11,700 shares and 8,082 shares previously held by the 2018 Trust were transferred to the Revocable Trust on August 22, 2019 and August 7, 2020, respectively.
Billionaire Hedge Funds
